Deciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic Hypotension

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorCentre Hospitalier Universitaire Vaudois

About this trial

Phase 1 objective: test the feasibility of using a 3Tesla MRI scanner instead of a 7Tesla MRI scanner to measure brainstem responses to LBNP in healthy participants.

Phase 2 primary objective: compare the brainstem responses to LBNP in patients with PD associated with OH to PD patients without OH using BOLD fMRI

Eligibility criteria

Qualifiers

Signed informed consent

Age ≥ 18 years and <75 years

Normal office blood pressure (<140/90 mmHg)

For women of childbearing potential: using or willing to use during the study a reliable contraception method compatible with MRI

Disqualifiers

Schellong test showing OH (drop of Systolic BP >20 mmHg or Diastolic BP >10 mmHg)

Pregnant or lactating women

Refusal to be informed of incidental findings

Any medication (acute or chronic prescription) except oral contraception

Trial design

Treatments tested in this trial

  • Lower body negative pressure

Treatment groups

130 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Centre Hospitalier Universitaire Vaudois

Lead sponsor

Ecole Polytechnique Fédérale de Lausanne

Collaborator

University Hospital, Geneva

Collaborator